Biggest News Aggregation in the World
📰 Aktx News

Page 4 - Aktx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aktx. Real-time updates on events, politics, business and more.

Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ AKTX opened at $0.19 on Friday. The stock has a 50-day simple moving average of $0.26 and a two-hundred […]
United Kingdom City Of Omnia Family Wealth Armistice Capital Akari Therapeutics Plc Zakari Therapeutics
Source: wkrb13.com

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report report published on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 5.3 % Shares of AKTX opened at $0.20 on Friday. The stock has a market cap of $14.90 million, a […]
City Of United Kingdom Armistice Capital Omnia Family Wealth Akari Therapeutics Company Profile Akari Therapeutics Plc

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report sent to investors on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright assumed coverage on Akari Therapeutics in a research report on Monday, December 5th. They set a buy rating and […]
City Of United Kingdom Akari Therapeutics Plc Omnia Family Wealth Armistice Capital Zakari Therapeutics

StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX)

Research analysts at StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright assumed coverage on Akari Therapeutics in a report on Monday, December 5th. They set a “buy” rating and a […]
United Kingdom City Of Armistice Capital Akari Therapeutics Plc Omnia Family Wealth Zakari Therapeutics
Source: wkrb13.com

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report issued on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright started coverage on Akari Therapeutics in a research report on Monday, December 5th. They set a buy rating and a $1.50 price objective […]
United Kingdom City Of Akari Therapeutics Plc Armistice Capital Omnia Family Wealth Zakari Therapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report released on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. NASDAQ:AKTX opened at $1.13 on Monday. Akari Therapeutics has a 1-year low of $1.05 and a 1-year high of $2.74. The firm has a fifty day […]
Omnia Family Wealth Wsfs Capital Management Citadel Advisors Millennium Management Akari Therapeutics Plc Zakari Therapeutics

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report published on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. NASDAQ AKTX opened at $1.10 on Friday. Akari Therapeutics has a 52 week low of $1.05 and a 52 week high of $3.20. The stock has […]
Akari Therapeutics Company Profile Get Rating Omnia Family Wealth Wsfs Capital Management Citadel Advisors Renaissance Technologies Millennium Management

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science